Sökning: onr:"swepub:oai:DiVA.org:uu-485906" > ELIXIR and Toxicolo...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05638naa a2201057 4500 | |
001 | oai:DiVA.org:uu-485906 | |
003 | SwePub | |
008 | 220929s2021 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4859062 URI |
024 | 7 | a https://doi.org/10.12688/f1000research.74502.12 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Martens, Marvin4 aut |
245 | 1 0 | a ELIXIR and Toxicology :b a community in development |
264 | c 2021-11-08 | |
264 | 1 | b F1000 Research Ltd,c 2021 |
338 | a electronic2 rdacarrier | |
520 | a Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmakologi och toxikologi0 (SwePub)301022 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmacology and Toxicology0 (SwePub)301022 hsv//eng |
653 | a Bioinformatics | |
653 | a Bioinformatik | |
700 | 1 | a Stierum, Rob4 aut |
700 | 1 | a Schymanski, Emma L.4 aut |
700 | 1 | a Evelo, Chris T.4 aut |
700 | 1 | a Aalizadeh, Reza4 aut |
700 | 1 | a Aladjov, Hristo4 aut |
700 | 1 | a Arturi, Kasia4 aut |
700 | 1 | a Audouze, Karine4 aut |
700 | 1 | a Babica, Pavel4 aut |
700 | 1 | a Berka, Karel4 aut |
700 | 1 | a Bessems, Jos4 aut |
700 | 1 | a Blaha, Ludek4 aut |
700 | 1 | a Bolton, Evan E.4 aut |
700 | 1 | a Cases, Montserrat4 aut |
700 | 1 | a Damalas, Dimitrios Ε.4 aut |
700 | 1 | a Dave, Kirtan4 aut |
700 | 1 | a Dilger, Marco4 aut |
700 | 1 | a Exner, Thomas4 aut |
700 | 1 | a Geerke, Daan P.4 aut |
700 | 1 | a Grafström, Roland4 aut |
700 | 1 | a Gray, Alasdair4 aut |
700 | 1 | a Hancock, John M.4 aut |
700 | 1 | a Hollert, Henner4 aut |
700 | 1 | a Jeliazkova, Nina4 aut |
700 | 1 | a Jennen, Danyel4 aut |
700 | 1 | a Jourdan, Fabien4 aut |
700 | 1 | a Kahlem, Pascal4 aut |
700 | 1 | a Klanova, Jana4 aut |
700 | 1 | a Kleinjans, Jos4 aut |
700 | 1 | a Kondic, Todor4 aut |
700 | 1 | a Kone, Boï4 aut |
700 | 1 | a Lynch, Iseult4 aut |
700 | 1 | a Maran, Uko4 aut |
700 | 1 | a Martinez Cuesta, Sergio4 aut |
700 | 1 | a Ménager, Hervé4 aut |
700 | 1 | a Neumann, Steffen4 aut |
700 | 1 | a Nymark, Penny4 aut |
700 | 1 | a Oberacher, Herbert4 aut |
700 | 1 | a Ramirez, Noelia4 aut |
700 | 1 | a Remy, Sylvie4 aut |
700 | 1 | a Rocca-Serra, Philippe4 aut |
700 | 1 | a Salek, Reza M.4 aut |
700 | 1 | a Sallach, Brett4 aut |
700 | 1 | a Sansone, Susanna-Assunta4 aut |
700 | 1 | a Sanz, Ferran4 aut |
700 | 1 | a Sarimveis, Haralambos4 aut |
700 | 1 | a Sarntivijai, Sirarat4 aut |
700 | 1 | a Schulze, Tobias4 aut |
700 | 1 | a Slobodnik, Jaroslav4 aut |
700 | 1 | a Spjuth, Ola,c Professor,d 1977-u Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)olspj499 |
700 | 1 | a Tedds, Jonathan4 aut |
700 | 1 | a Thomaidis, Nikolaos4 aut |
700 | 1 | a Weber, Ralf J.M.4 aut |
700 | 1 | a van Westen, Gerard J.P.4 aut |
700 | 1 | a Wheelock, Craig E.4 aut |
700 | 1 | a Williams, Antony J.4 aut |
700 | 1 | a Witters, Hilda4 aut |
700 | 1 | a Zdrazil, Barbara4 aut |
700 | 1 | a Županič, Anže4 aut |
700 | 1 | a Willighagen, Egon L.4 aut |
710 | 2 | a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org |
773 | 0 | t F1000 Researchd : F1000 Research Ltdg 10, s. 1129-1129q 10<1129-1129x 2046-1402 |
856 | 4 | u https://doi.org/10.12688/f1000research.74502.1y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1699798/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 | u https://f1000research.com/articles/10-1129/v1/pdf |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485906 |
856 | 4 8 | u https://doi.org/10.12688/f1000research.74502.1 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy